دورية أكاديمية

Outcomes of Ultrasound-guided Glen Humeral Corticosteroid Injections in Adhesive Capsulitis

التفاصيل البيبلوغرافية
العنوان: Outcomes of Ultrasound-guided Glen Humeral Corticosteroid Injections in Adhesive Capsulitis
المؤلفون: Song, Amos, Katz, Jeffrey N., Higgins, Laurence D., Newman, Joel, Gomoll, Andreas, Jain, Nitin B.
المصدر: Song, Amos, Jeffrey N. Katz, Laurence D. Higgins, Joel Newman, Andreas Gomoll, and Nitin B. Jain. 2016. “Outcomes of Ultrasound-guided Glen Humeral Corticosteroid Injections in Adhesive Capsulitis.” British journal of medicine and medical research 5 (5): 570-578. doi:10.9734/BJMMR/2015/13478. http://dx.doi.org/10.9734/BJMMR/2015/13478Test.
سنة النشر: 2016
المجموعة: HMS Scholarly Articles
SPH Scholarly Articles
مصطلحات موضوعية: Ultrasound, corticosteroids, adhesive capsulitis, injections
الوصف: Aims To assess short and longer-term outcomes of ultrasound-guided glenohumeral corticosteroid injections for adhesive capsulitis. Study Design A mixed prospective and retrospective study design Place and Duration of Study Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Department of Orthopaedic Surgery, Brigham and Women’s Hospital, between June 2011 and July 2012. Methodology Using medical records, we first retrospectively identified patients who had received ultrasound-guided injections of lidocaine and triamcinolone for adhesive capsulitis We then assessed short-term follow-up outcomes (within 3 months of procedure) using medical record review and phone interviews. Longer-term follow-up (at least 3 months from the procedure) outcomes were determined by mailings and phone calls. Average and worst shoulder pain scores were measured on a visual analog scale. Shoulder ROM was measured in forward flexion, isolated abduction, and external rotation. Results: Patients presented an average of 5.1 (SD=4.1) months after onset of symptoms. Within three months of the injection, 55.9% (95% CI: 39.2%, 72.6%) of patients reported greater than 75% pain relief and 44.1% (95% CI: 27.4%, 60.8%) of patients reported greater than 75% ROM improvement. The percentage of patients who improved increased with increased duration of follow-up. At short-term follow-up (mean=2.1 months, SD=2.7), average pain decreased from 5.6 (SD=2.2) to 3.0 (SD=1.8) (p ≤ .001) and worst pain decreased from 7.8 (SD=1.2) to 4.3 (SD=3.2) (p ≤ .001). At longer-term follow-up (mean =10.4 months, SD=3.7), average pain decreased to 1.9 (SD=1.9) (p ≤ .001) and worst pain decreased to 2.9 (SD=2.3) (p ≤ .001). Conclusion: A majority of patients had significant pain reduction and functional improvement after an ultrasound guided glenohumeral corticosteroid injection for adhesive capsulitis. Our patients experience the majority of their pain and functional relief within the first three months after an ultrasound-guided corticosteroid injection with continued increase in relief in the longer-term.
نوع الوثيقة: Journal Article
اللغة: English
تدمد: 2231-0614
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824683/pdfTest/; British journal of medicine and medical research
DOI: 10.9734/BJMMR/2015/13478
الوصول الحر: http://nrs.harvard.edu/urn-3:HUL.InstRepos:26860323Test
حقوق: open
URL: http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAATest
رقم الانضمام: edshld.1.26860323
قاعدة البيانات: Digital Access to Scholarship at Harvard (DASH)
الوصف
تدمد:22310614
DOI:10.9734/BJMMR/2015/13478